Literature DB >> 9577241

From normal fear to pathological anxiety.

J B Rosen1, J Schulkin.   

Abstract

In this article the authors address how pathological anxiety may develop from adaptive fear states. Fear responses (e.g., freezing, startle, heart rate and blood pressure changes, and increased vigilance) are functionally adaptive behavioral and perceptual responses elicited during danger to facilitate appropriate defensive responses that can reduce danger or injury (e.g., escape and avoidance). Fear is a central motive state of action tendencies subserved by fear circuits, with the amygdala playing a central role. Pathological anxiety is conceptualized as an exaggerated fear state in which hyperexcitability of fear circuits that include the amygdala and extended amygdala (i.e., bed nucleus of the stria terminalis) is expressed as hypervigilance and increased behavioral responsivity to fearful stimuli. Reduced thresholds for activation and hyperexcitability in fear circuits develop through sensitization- or kindling-like processes that involve neuropeptides, hormones, and other proteins. Hyperexcitability in fear circuits is expressed as pathological anxiety that is manifested in the various anxiety disorders.

Entities:  

Mesh:

Year:  1998        PMID: 9577241     DOI: 10.1037/0033-295x.105.2.325

Source DB:  PubMed          Journal:  Psychol Rev        ISSN: 0033-295X            Impact factor:   8.934


  151 in total

1.  The association between anxiety and psychopathy dimensions in children.

Authors:  P J Frick; S O Lilienfeld; M Ellis; B Loney; P Silverthorn
Journal:  J Abnorm Child Psychol       Date:  1999-10

2.  Fear and feeding in the nucleus accumbens shell: rostrocaudal segregation of GABA-elicited defensive behavior versus eating behavior.

Authors:  S M Reynolds; K C Berridge
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

3.  Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats.

Authors:  J A Rosenkranz; A A Grace
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

4.  Acquisition and extinction of a conditioned passive avoidance reflex in mice with genetic knockout of monoamine oxidase A.

Authors:  N I Dubrovina; N K Popova; M A Gilinskii; R A Tomilenko; I Seif
Journal:  Neurosci Behav Physiol       Date:  2006-05

5.  Graded fear generalization enhances the level of cfos-positive neurons specifically in the basolateral amygdala.

Authors:  Abha K Rajbhandari; Ruoyan Zhu; Cora Adling; Michael S Fanselow; James A Waschek
Journal:  J Neurosci Res       Date:  2016-09-23       Impact factor: 4.164

6.  Anticipatory prefrontal cortex activity underlies stress-induced changes in Pavlovian fear conditioning.

Authors:  Adam M Goodman; Nathaniel G Harnett; Muriah D Wheelock; Danielle R Hurst; Tyler R Orem; Ethan W Gossett; Chelsea A Dunaway; Sylvie Mrug; David C Knight
Journal:  Neuroimage       Date:  2018-03-16       Impact factor: 6.556

7.  Reversal of established traumatic brain injury-induced, anxiety-like behavior in rats after delayed, post-injury neuroimmune suppression.

Authors:  Krista M Rodgers; Yuetiva K Deming; Florencia M Bercum; Serhiy Y Chumachenko; Julie L Wieseler; Kirk W Johnson; Linda R Watkins; Daniel S Barth
Journal:  J Neurotrauma       Date:  2013-11-20       Impact factor: 5.269

8.  Behavioral effects of chronically elevated corticosterone in subregions of the medial prefrontal cortex.

Authors:  Joshua D Croteau; Jay Schulkin; Jack D Shepard
Journal:  Behav Brain Res       Date:  2016-08-28       Impact factor: 3.332

9.  Moderators of the Relation between Shyness and Behavior with Peers: Cortisol Dysregulation and Maternal Emotion Socialization.

Authors:  Elizabeth L Davis; Kristin A Buss
Journal:  Soc Dev       Date:  2012-02-15

10.  Stress response and the adolescent transition: performance versus peer rejection stressors.

Authors:  Laura R Stroud; Elizabeth Foster; George D Papandonatos; Kathryn Handwerger; Douglas A Granger; Katie T Kivlighan; Raymond Niaura
Journal:  Dev Psychopathol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.